As reported by NHE, e new at-home test for cardiovascular disease, integrated into the NHS app, offers quick results and convenient follow-up options for patients
The integration allows patients to carry out a test for cardiovascular disease, with results given in just nine minutes. It provides patients with:
A full cholesterol panel test
Their heart age
10-year risk of a heart attack or stroke
BMI score
Access to follow-up treatment options if necessary
The service has been used by thousands across the country, with initial roll-outs via pharmacies, community centres, and NHS partnerships in North East and North Cumbria, West Yorkshire, Cambridge and Peterborough, and Cornwall.
“The evidence behind the value of early detection of Cardio, Metabolic and Renal disease is very clear,” explained Dr Neil Paul, a senior GP in Cheshire.
“Services like this can free up time in our surgery and the integration with the patient record means I am getting data on patients whom I would not normally be aware of — it’s a win-win.”
It is estimated by The King’s Fund that cardiovascular disease costs the NHS around £7.4bn annually — and the wider economy £15.8bn.
This test could help with early detection as it enables people to undertake blood tests, learn about the disease, share their results with the NHS almost instantly; this process can take weeks currently. The integration is made possible by UK digital diagnostics company PocDoc.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment